Evolent Health (NYSE:EVH – Get Free Report) and AEye (NASDAQ:LIDR – Get Free Report) are both small-cap computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, dividends, analyst recommendations, earnings and profitability.
Institutional & Insider Ownership
21.6% of AEye shares are held by institutional investors. 1.6% of Evolent Health shares are held by company insiders. Comparatively, 11.9% of AEye shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Analyst Recommendations
This is a breakdown of current ratings and price targets for Evolent Health and AEye, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Evolent Health | 1 | 1 | 14 | 0 | 2.81 |
| AEye | 1 | 0 | 1 | 0 | 2.00 |
Profitability
This table compares Evolent Health and AEye’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Evolent Health | -6.24% | 1.79% | 0.65% |
| AEye | -19,320.88% | -102.95% | -74.93% |
Earnings and Valuation
This table compares Evolent Health and AEye”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Evolent Health | $2.55 billion | 0.18 | -$61.62 million | ($1.58) | -2.63 |
| AEye | $200,000.00 | 488.90 | -$35.46 million | ($2.17) | -1.00 |
AEye has lower revenue, but higher earnings than Evolent Health. Evolent Health is trading at a lower price-to-earnings ratio than AEye, indicating that it is currently the more affordable of the two stocks.
Risk and Volatility
Evolent Health has a beta of 0.26, suggesting that its share price is 74% less volatile than the S&P 500. Comparatively, AEye has a beta of 2.97, suggesting that its share price is 197% more volatile than the S&P 500.
About Evolent Health
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
About AEye
AEye, Inc., together with its subsidiaries, provides lidar systems for vehicle autonomy, advanced driver-assistance systems, and robotic vision applications in the United States, Europe, and Asia-Pacific. It offers 4Sight intelligent sensing lidar platform, including 4Sight at Design, Triggered 4Sight, Responsive 4Sight, and Predictive 4Sight; and 4Sight for automotive and industrial market. The company was formerly known as CF Finance Acquisition Corp. III and changed its name to AEye, Inc. in August 2021. AEye, Inc. was founded in 2013 and is headquartered in Dublin, California.
Receive News & Ratings for Evolent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolent Health and related companies with MarketBeat.com's FREE daily email newsletter.
